Stabilization of pharmaceuticals to oxidative degradation

Pharmaceutical Development and Technology

Volumn 7, Issue 1, 2002, Pages 1-32

  Waterman, Kenneth C ^a   Adami, Roger C ^a   Alsante, Karen M ^a   Hong, Jinyang ^a   Landis, Margaret S ^a   Lombardo, Franco ^a   Roberts, Christopher J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADIPIC ACID; ALPHA TOCOPHEROL; AMITRIPTYLINE; ANTIOXIDANT; ASCORBIC ACID; ASCORBYL PALMITATE; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CAPTOPRIL; CHLORPROMAZINE; DEXTROMETHORPHAN; DRUG ADDITIVE; EDETIC ACID; FLUOXETINE; FLURAZEPAM; GALLIC ACID PROPYL ESTER; GAMMA TOCOPHEROL; LABETALOL; MORPHINE; PHENYLBUTAZONE; PHOSPHATIDYLCHOLINE; POLYCARBONATE; POLYETHYLENE DERIVATIVE; POLYETHYLENE TEREPHTHALATE; POLYPROPYLENE; POLYSTYRENE; POLYVINYLCHLORIDE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PACKAGING; LITERATURE; OXIDATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOLID STATE;

ANTIOXIDANTS; CATALYSIS; CHEMISTRY, PHARMACEUTICAL; DNA; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; OXIDATION-REDUCTION; PROTEINS; SOLUBILITY; STERILIZATION;

EID: 0036395858     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120002237     Document Type: Review

References (135)

1. Solomons, T.W.G. Organic Chemistry, 5th Ed.; John Wiley and Sons: New York, 1992; 449.
2. March, J. Advanced Organic Chemistry, 4th Ed.; John Wiley and Sons: New York, 1992; 1158.
3. Menger, F.M.; Mandell, L. Electronic Interpretation of Organic Chemistry; Plenum Press: New York, 1980; 27.
4. Brittain, H. Personal communication.
5. Singh, S.; Bakshi, M. Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs. Pharmacol. Technol. 2000; 1-14 (General references to stress tests, http://www.pharmaportal.com/articles).
6. Alsante, K.M.; Friedmann, R.C.; Hatajik, T.D.; Lohr, L.L.; Sharp, T.S.; Snyder, K.D.; Szczesny, E.J. Degradation and Impurity Analysis for Pharmaceutical Drug Candidates. In Handbook of Modern Pharmaceutical Analysis; Ahuja, S., Scypinski, S., Eds.; (General references to stress tests, Chapter 4) Academic Press: Boston, 2002, in press.
7. Carstensen, J.T. Drug Stability Principles and Practices, 2nd Ed.; Marcel Dekker, Inc.: New York, 1995; Vol. 68.
8. Hudlicky, M. Oxidations in Organic Chemistry - 186; American Chemical Society: Washington, DC, 1990.
9. Boccardi, G. Autoxidation of Drugs: Prediction of Degradation Impurities from Results with Radical Chain Initiators. Farmaco 1994, 49 (6), 431-435.
10. Howard, J.A. Free Radicals; John Wiley and Sons: New York, 1973; Vol. 2.
11. Porter, N.A. Membrane Lipid Oxidation; CRC Press: Boca Raton, 1990; Vol. 1.
12. Huyser, E.S. Free Radical Chain Reactions; Wiley-Interscience: New York, 1970.
13. Bard, A.J.; Faulkner, L. Electrochemical Methods: Fundamentals and Applications, 2nd Ed.; John Wiley and Sons: New York, 2000; 479-480.
14. Wilson, T.D. Structural Influences on the Amperometric Detection of Opiates in High Performance Liquid Chromatography. J. Chromatogr. 1984, 301, 39-46 (Note that this potential is a polarographic half-wave potential).
15. Ryan, E.; Gamache, P.; Acworth, I.; ESA, Inc. Poster presented at the 43rd Pittsburgh Conference and Exposition, New Orleans, March 1992.
16. Blessel, K.W.; Rudy, B.C.; Senkowski, B.Z. Analytical Profiles of Drug Substances; Academic Press: New York, 1974; Vol. 3, 127-147.
17. Risley, D.S.; Bopp, R.J. Analytical Profiles of Drug Substances; Academic Press: New York, 1990; Vol. 19, 193-219.
18. Rudy, B.C.; Senkowski, B.Z. Analytical Profiles of Drug Substances; Academic Press: New York, 1974; Vol. 3, 307-331.
19. Ranta, V.-P.; Urtti, A.; Auriola, S. Gradient High-Performance Liquid Chromatography Analysis of Enkephalin Peptides, Their Metabolites and Enzyme Inhibitors Using Combined Ultraviolet and Electrochemical Detection. J. Chromatogr. Anal. 1997, 766, 85-97.
20. Connors, K.A.; Amidon, G.L.; Stella, V.J. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists, 2nd Ed.; John Wiley and Sons: New York, 1986; 93-94, see also pp 161-808.
21. Lombardo, F.; Campos, G.; Caldwell, C.J. Pfizer Corporation, unpublished results.
22. Chan, H.K.; Fogg, A.G. Voltammetric Determination of Phenylbutazone and Oxyphenylbutazone at a Glassy Carbon Electrode. Anal. Chim. Acta 1979, 109, 341-349.
23. Oungpipat, W.; Southwell-Keely, P.; Alexander, P.W. Flow Injection Detection of Tetracyclines by Electrocatalytic Oxidation at a Nickel-Modified Glassy Carbon Electrode. Analyst 1995, 120, 1559-1565.
24. Leeson, L.J.; Weidenheimer, J.F. Stability of Tetracycline and Riboflavin. J. Pharm. Sci. 1969, 58, 355-357.
25. Kerr, J.A. Bond Dissociation Energies by Kinetic Methods. Chem. Rev. 1966, 66 (5), 465-500.
26. Lowry, T.H.; Richardson, K.S. Mechanism and Theory in Organic Chemistry, 3rd Ed.; Harper and Row: New York, 1987; 161-162.
27. Hoellering, R.; Gasteiger, J.; Steinhauer, L.; Schultz, P.-P.; Herwig, A. Simulation of Organic Reactions from the Degradation of Chemicals to Combinatorial Synthesis. J. Chem. Inf. Comput. Sci. 2000, 40, 482-494.
28. Ihlenfeldt, W.D.; Gasteiger, J. Computer Assisted Planning of Organic Synthesis: The Second Generation of Programs. Angew. Chem., Int. Ed. Engl. 1996, 34 (23/24), 2613-2633.
29. Judson, P.N.; Lea, H. Accessing Knowledge About Chemical Synthesis by Computer. Chim. Oggi 1996, 14 (9), 21-24.
30. Available at http://www.epa.gov/oppt/exposure/docs/episuited/.htm〈DLForm.htm〉
31. Vogue, P. Syracuse Research Corporation's Environmental Fate Data Bases. J. Chem. Inf. Comput. Sci. 1996, 36 (3), 615.
32. Jorgensen, W.L.; Laird, E.R.; Gushurst, A.J.; Fleischer, J.M.; Gothe, S.A.; Helson, H.E.; Pederes, G.D.; Sinclair, S. CAMEO: A Program for the Logical Prediction of Products of Organic Reactions. Pure Appl. Chem. 1990, 62, 1921-1932.
33. Walling, C. Some Properties of Radical Reactions in Synthesis. Tetrahedron 1985, 41 (19), 3887-3900.
34. Howard, J.A. Homogeneous Liquid Phase Autoxidations. Free Radic. 1973, 2, 3-62.
35. Maillard, B.; Ingold, K.U.; Scaiano, J.C. Rate Constants for the Reactions of Free Radicals with Oxygen in Solution. J. Am. Chem. Soc. 1983, 105, 5095-5099.
36. Von Sonntag, C.; Schuchmann, H.-P. Peroxyl Radicals in Aqueous Solutions. In Peroxyl Radicals; Alfassi, Z.B., Ed.; John Wiley and Sons: New York, 1997; 173-234.
37. Porter, N. Personal communication.
38. Ingold, K.U. Peroxy Radicals. Acc. Chem. Res. 1969, 2 (1), 1-9.
39. Russell, G.A. Deuterium-Isotope Effects in the Autoxidation of Aralkyl Hydrocarbons. Mechanisms of the Interaction of Peroxy Radicals. J. Am. Chem. Soc. 1957, 79, 3871-3877.
40. - Radicals in Aqueous Solution. In Peroxyl Radicals; Wiley: Chichester, 1997; 407-437.
41. Rigo, A.; Scarpa, M. Generation of Superoxide in the Autoxidation of Ascorbate and Glutathione. In Oxygen Radicals in Chemistry and Biology; Walter de Gruyter and Co.: Berlin, 1984; 171-176.
42. Hartauer, K.J.; Arbuthnot, G.N.; Baetschi, S.W.; Johnson, R.A.; Luke, W.D.; Pearson, N.G.; Rickard, E.C.; Tingle, C.A.; Tsang, P.K.S.; Wiens, R.E. Influence of Peroxide Impurities in Povidone and Crospovidone on the Stability of Raloxifene Hydrochloride in Tablets: Identification and Control of an Oxidative Degradation Product. Pharm. Dev. Technol. 2000, 5, 303-310.
43. Buhler, V. Kollidone; 2nd Ed., BASF Aktiengesellschaft: Ludwigshafen, Germany, 1993.
44. Union Carbide Customer Support Information.
45. Dubost, D.C.; Kaufman, M.J.; Zimmerman, J.A.; Bogusky, M.J.; Coddington, A.B.; Pitzenberger, S.M. Characterization of a Solid State Reaction Product from a Lyophilized Formulation of a Cyclic Heptapeptide. A Novel Example of an Excipient-Induced Oxidation. Pharm. Res. 1996, 13 (12), 1811-1814.
46. Hancock, B.C.; Zografi, G. Characteristics and Significance of the Amorphous State in Pharmaceutical Systems. J. Pharm. Sci. 1997, 86 (1), 1-12.
47. Miller, D.M.; Buettner, G.R.; Aust, S.D. Transition Metals as Catalysts for "Autoxidation" Reactions. Free Radic. Biol. Med. 1990, 8 (1), 95-108.
48. Koppenol, W.H. Free Radical Damage and Its Control. In New Comprehensive Biochemistry; Rice-Evans, C.A., Burdon, R.H., Eds.; Elsevier: Amsterdam, 1994; 3-24.
49. Buettner, G.R.; Jurkiewicz, B.A. Catalytic Metals, Ascorbate and Free Radicals: A Combination to Avoid. Radiat. Res. 1996, 145 (5), 532-541.
50. Taqui Khan, M.M.; Matell, A.E. Homogeneous Catalysis by Metal Complexes; Academic Press, New York, 1974, vol 1, 143-149.
51. MacFaul, P.A.; Wayner, D.D.M. Ingold, K.U. A Radical Account of "Oxygenated Fenton Chemistry". Acc. Chem. Res. 1998, 31 (4), 159-162.
52. Roth, H.J. Photochemistry and Pharmaceuticals. Farm Glas. 1968, 24 (8-9), 349-359.
53. Szwarc, M.; Streitwieser, A.; Mowery, P.C. Ions and Ion Pairs in Organic Reactions; John Wiley and Sons: New York, 1974; Vol. 2, Chapter 2.
54. Lowry, T.H.; Richardson, K.S. Mechanism and Theory in Organic Chemistry, 3rd Ed.; Harper and Row: New York, 1987; 177-180.
55. Lowry, T.H.; Richardson, K.S. Mechanism and Theory in Organic Chemistry, 3rd Ed.; Harper and Row: New York, 1987; 297-298.
56. Weast, R.C., (Ed.) Handbook of Chemistry and Physics, 52nd Ed.; The Chemical Rubber Co.: Ohio, 1971.
57. Streitweiser, A., Jr; Heathcock, C.H. Introduction to Organic Chemistry, 2nd Ed.; Macmillan Publishing Co.: New York, 1981; 938.
58. Kibbe, A.H., (Ed.) Handbook of Pharmaceutical Excipients, 3rd Ed.; American Pharmaceutical Association: Washington, DC, 2000.
59. Byrn, S.R.; Pfeiffer, R.R.; Stowell, J.G. Solid-State Chemistry of Drugs, 2nd Ed.; SSCI: West Lafayette, 1999.
60. Crowley, P.J. Excipients as Stabilizers. Pharm. Sci. Technol. Today 1999, 2, 237-243.
61. Bennett, J.E.; Root, K.D.J. Free Radicals in the Solid State. Electron Spin Reson. 1972, 1, 118-155.
62. Garcia-Garibay, M. Personal communication.
63. Duddu, S.P.; Weller, K. Importance of Glass Transition Temperature in Accelerated Stability Testing of Amorphous Solids: Case Study Using a Lyophilized Aspirin Formulation. J. Pharm. Sci. 1996, 85, 345-347.
64. Akers, M.J. Preformulation Screening of Antioxidant Efficiency in Parenteral Solutions. J. Parenter. Drug Assoc. 1979, 33 (6), 346-356.
65. Parasrampuria, J.; Li, L.; Dudleston, A.; Zhang, H. The Impact of an Autoclave Cycle on the Chemical Stability of Parenteral Products. J. Parenter. Sci. Technol. 1993, 47 (4), 177-179.
66. Akers, J.; Agalloco, J. Sterility and Sterility Assurance PDA. J. Pharm. Sci. Technol. 1997, 51 (2), 27-77.
67. Duncan, M.R.; Wang, P.L.; Moldenhauer, J.E. Determining the Capability of a Drug Product to Be Terminally Sterilized: A Case Study Involving a Heat-Sensitive, Oxygen Sensitive Drug Product. Pharm. Dev. Technol. 1998, 3 (4), 527-534.
68. Jacobs, G.P. A Review of the Effects of Gamma Radiation on Pharmaceutical Materials. J. Biomater. Appl. 1995, 10 (7), 59-83.
69. Reid, B.R. Gamma Processing Technology: An Alternative Technology for Terminal Sterilization of Parenterals. J. Pharm. Sci. Technol. 1995, 49 (2), 83-88.
70. Jacobs, G.P. Gamma Radiation Sterilization. In Encyclopedia of Pharmaceutical Technology; Marcel Dekker, Inc.: New York, 1992; 305-328.
71. Gopal, N.G.S. Radiation Sterilization of Pharmaceuticals and Polymers. Radiat. Phys. Chem. 1978, 12, 35-50.
72. Pandula, E.; Farkas, E. Elimination of Gamma-Induced Radiation in Aqueous Pharmaceutical Preparations. Acta Pharm. Hung. 1969, 40, 165-169.
73. am Ende, M.T.; Peppas, N.A. FTIR Spectroscopic Investigation and Modeling of Solute/Polymer Interactions in the Hydrated State. J. Biomater. Sci. Polym. Edn. 1999, 10, 1289-1302.
74. Donbrow, M. Stability of the Polyoxyethylene Chain. Surfactant Sci. Ser. 1987, 23 (Nonionic Surfactants), 1011-1073.
75. Cleland, J.L.; Powell, M.F.; Shire, S.J. The Development of Stable Protein Formulations: A Close Look at Protein Aggregation, Deamidation, and Oxidation. Crit. Rev. Ther. Drug Carrier Sys. 1993, 10, 307-377.
76. Lai, M.C.; Topp, E.M. Solid-State Chemical Stability of Proteins and Peptides. J. Pharm. Sci. 1999, 88, 489-500.
77. McNally, E.J., (Ed.) Protein Formulation and Delivery; Marcel Dekker, Inc.: New York, 2000; 111-200.
78. Halliwell, B.; Gutteridge, M.C. Role of Free Radicals and Catalytic Metal Ions in Human Disease: An Overview. In Methods in Enzymology: Free Radicals and Metal Ions in Human Disease; Academic Press: New York, 1990; Vol. 186, 1-85.
79. Means, G.E.; Feeney, R.E. Chemical Modification of Proteins; Holden-Day, Inc.: San Francisco, 1971; 1-254.
80. Foote, C.S. Mechanisms of Photosensitized Oxidation. Science 1968, 162 (3857), 963-970.
81. Matheson, I.B.C.; Lee, J. Chemical Reaction Rates of Amino Acids with Singlet Oxygen. Photochem. Photobiol. 1979, 29 (5), 879-881.
82. Sluyterman, L.A.Æ. Photooxidation, Sensitized by Proflavine, of a Number of Protein Constituents. Biochim. Biophys. Acta 1962, 60, 557-561.
83. Spikes, J.D.; Straight, R. Sensitized Photochemical Processes in Biological Systems. Ann. Rev. Phys. Chem. 1967, 18, 409-436.
84. Pikal, M.J.; Dellerman, K.; Roy, M.L. Formulation and Stability of Freeze-Dried Proteins: Effects of Moisture and Oxygen on the Stability of Freeze-Dried Formulations of Human Growth Hormone. Dev. Biol. Stand. 1992, 74, 21-38.
85. McDermott, M.; Chiesa, R.; Roberts, J.E.; Dillon, J. Photooxidation of Specific Residues in α-Crystallin Polypetides. Biochemistry 1991, 30 (35), 8653-8660.
86. Rietveld, A.W.M.; Ferreira, S.T. Kinetics and Energetics of Subunit Dissociation/Unfolding of TIM: The Importance of Oligomerization for Conformational Persistence and Chemical Stability of Proteins. Biochemistry 1998, 37 (3), 933-937.
87. Xie, M.; Schowen, R.L. Secondary Structure and Protein Deamidation. J. Pharm. Sci. 1999, 88 (1), 8-13.
88. Farber, J.M.; Levine, R.L. Sequence of Peptide Susceptible to Mixed Function Oxidation. Probable Cation Binding Site in Glutamine Synthetase. J. Biol. Chem. 1986, 261 (10), 4574-4578.
89. Hovorka, S.W.; Hong, J.; Cleland, J.L.; Schoeneich, C. Metal-Catalyzed Oxidation of Human Growth Hormone: Modulation by Solvent-Induced Changes of Protein Conformations. J. Pharm. Sci. 2001, 90 (1), 58-69.
90. Stadtman, E.R. Oxidation of Free Amino Acids and Amino Acid Residues in Proteins by Radiolysis and by Metal-Catalyzed Reactions. Ann. Rev. Biochem. 1993, 62, 797-821.
91. Sanches, R.; Melo, W.L.B.; Columbo, M.F. Effects of Hydration in the Oxygenation and Autoxidation of Carbonmonoxyhemoglobin Powder. Biochim. Biophys. Acta 1996, 874 (1), 19-22.
92. Karel, M. Free Radicals in Low Moisture Systems. In Water Relations in Foods, Proceedings of International Symposium; Duckworth, R.B., Ed.; Academic Press: New York, 1975; 435-453.
93. Smith, J.; Zhang, Y.; Niven, R. Toward Development of a Non-viral Gene Therapeutic. Adv. Drug Deliv. Rev. 1997, 26 (2,3), 135-150.
94. Wolff, J.A. Naked DNA Gene Transfer in Mammalian Cells. The Development of Human Gene Therapy; Cold Spring Harbor Monogram Series 36, 1999; 279-307.
95. Evans, R.K.; Xu, Z.; Bohannon, K.E.; Wang, B.; Bruner, M.W.; Volkin, D.B. Evaluation of Degradation Pathways for Plasmid DNA in Pharmaceutical Formulations via Accelerated Stability Studies. J. Pharm. Sci. 2000, 89 (1), 76-87.
96. Anchordoquy, T.J.; Koe, G.S. Physical Stability of Nonviral Plasmid-Based Therapeutics. J. Pharm. Sci. 2000, 89 (3), 289-296.
97. Adami, R.C.; Collard, W.T.; Gupta, S.A.; Kwok, K.Y.; Bonadio, J.; Rice, K.G. Stability of Peptide-Condensed Plasmid DNA Formulations. J. Pharm. Sci. 1998, 87 (6), 678-683.
98. Lindahl, T. Instability and Decay of the Primary Structure of DNA. Nature (Lond.) 1993, 362 (6422), 709-715.
99. Aust, A.E.; Eveleigh, J.F. Mechanisms of DNA Oxidation. Soc. Exp. Biol. Med. 1999, 222 (3), 246-251.
100. Núñez, M.E.; Hall, D.B.; Barton, J.K. Long-Range Oxidative Damage to DNA: Effects of Distance and Sequence. Chem. Biol. 1999, 6 (2), 85-97.
101. Steenken, S.; Javanovic, S.V. How Easily Oxidizable Is DNA? One-Electron Reductive Potentials of Adenosine and Guanosine Radicals in Aqueous Solution. J. Am. Chem. Soc. 1997, 119, 617-618.
102. Viswanathan, A.; Doestsch, P.W. Effects of Nonbulky DNA Base Damages on Escherichia coli RNA Polymerase-Mediated Elongation and Promoter Clearance. J. Biol. Chem. 1998, 273 (33), 21276-21281.
103. Araki, K.; Silva, C.A.; Toma, H.E.; Catalani, L.H.; Medeiros, M.H.; Mascio, P.D. Zinc Tetraruthenated Porphyrin Binding and Photoinduced Oxidation of Calf Thymus DNA. J. Inorg. Biochem. 2000, 78 (4), 269-273.
104. Middaugh, C.R.; Evans, R.K.; Montgomery, D.L.; Casimiro, D.R. Analysis of Plasmid DNA from a Pharmaceutical Perspective. J. Pharm. Sci. 1998, 87 (2), 130-146.
105. Thompson, J.A. A Review of High-Performance Liquid Chromatography in Nucleic Acids Research III. Isolation, Purification and Analysis of Supercoiled Plasmid DNA. Biochromatography 1986, 1 (2), 68-71 (see also pp 74-80).
106. de Carmejane, O.; Schwinefus, J.J.; Morris, M.D. Plasmid Topoisomer Separation by Capillary Gel Electrophoresis. Proc. SPIE-Int. Soc. Opt. Eng. 1999, 3602 (Advances in Fluorescence Sensing Technology IV), 346-354.
107. Billany, M.R.; Khatib, K.; Gordon, M.; Sugden, J.K. Alcohols and Ethanolamines as Hydroxyl Radical Scavengers. Int. J. Pharm. 1996, 137, 143-147.
108. Gordon, A.J.; Ford, R.A. The Chemists' Companion; John Wiley and Sons: New York, 1972.
109. Wolff, S.P. Ferrous Ion Oxidation in Presence of Ferric Ion Indicator Xylenol Orange for Measurement of Hydroperoxides. Methods Enzymol. 1994, 233, 182-189.
110. Bruton, G.W.; Ingold, K.U. Autoxidation of Biological Molecules. Antioxidant Activity of Vitamin E and Related Chain-Breaking Phenolic Antioxidants In Vitro. J. Am. Chem. Soc. 1981, 103 (21), 6472-6477.
111. Doba, T.; Burton, G.W.; Ingold, K.U. EPR Spectra of Some α-Tocopherol Model Compounds. Polar and Conformational Effect and Their Relation to Antioxidant Activities. J. Am. Chem. Soc. 1983, 105 (21), 6505-6506.
112. Burton, G.W.; Doba, T.; Gabe, E.; Hughes, L.; Lee, F.L.; Prasad, L.; Ingold, K.U. Autoxidation of Biological Molecules. Maximizing the Antioxidant Activity of Phenols. J. Am. Chem. Soc. 1985, 107 (24), 7053-7065.
113. Porter, N.A. Mechanisms for the Autoxidation of Polyunsaturated Lipids. Acc. Chem. Res. 1986, 19 (9), 262-268.
114. Akers, M.J. Antioxidants in Pharmaceutical Products. J. Parenter. Sci. Technol. 1982, 36 (5), 222-228.
115. Buettner, G.R. Spin Trapping: ESR Parameters of Spin Adducts. Free Radic. Biol. Med. 1987, 3 (4), 259-303.
116. Walling, C. Fenton's Reagent Revisited. Acc. Chem. Res. 1975, 8 (4), 125-131.
117. Rush, J.D.; Koppenol, W.H. Oxidative Intermediates in the Reaction of Ferrous EDTA with Hydrogen Peroxide. Reactions with Organic Molecules and Ferrocytochrome c. J. Biol. Chem. 1986, 261, 6730-6733.
118. Klaui, H. Tocopherol, Carotene and Ascorbyl Palmitate. Int. Flavors Food Addit. 1976, 7, 165-171.
119. Acarturk, F. The Effect of Cyclodextrines on the Physical and Chemical Stability of Drugs. Effect on Solid State Stability. FABAD Farm. Bilimler Derg. 1993, 18 (2), 77-85.
120. Lutz, B.; Volker, M. Cyclodextrins-Molecular Capsules with Useful Cavities. Prax. Nuturwiss. Chem. 1990, 39, 10-17.
121. Duchene, D.; Debrueres, B.; Vaution, C. Improvement of Drug Stability by Cyclodextrin Inclusion Complexation. S.T.P. Pharma 1985, 1, 37-43.
122. Eastman Chemical Company product information on bottle polymer materials.
123. Wang, Y.; Easteal, A.J.; Chen, X.D. Ethylene and Oxygen Permeability Through Polyethylene Packaging Films. Packag. Technol. Sci. 1998, 11, 169-178.
124. Forcinio, H. Choosing a Blister Material. Pharm. Technol. 2000, May, 26-30.
125. Taborsky, C.J.; Foster, M.G.; Lockhart, H.; Polgar, B. Permeation of Unit-Dose Blister Market Containers Under USP and ICH Conditions. Pharm. Technol. 2000, August, 38-42.
126. Pilchik, R. Pharmaceutical Blister Packaging, Part 1, Rationale and Materials. Pharm. Technol. 2000, November, 68-77.
127. Pavanetto, F.; Gento, I.; Conti, B.; Modena, T.; Montanori, L. Investigation on the Contribution of Raw Materials and of the Primary Container on Aluminum, Cadmium and Lead Contamination of Large-Volume Parenteral Solutions. Int. J. Pharm. 1989, 54 (2), 143-148.
128. Avis, K.E.; Levchuk, J.W. Remington: Science and Practice of Pharmacy, 19th Ed.; Gennaro, A.R., Ed.; Mack Publishing Co.: Easton, PA, 1995; Vol. 2, 1531.
129. Sanga, S.V. Review of Glass Types Available for Packaging Parenteral Solutions. J. Parenter. Drug Assoc. 1979, 33 (2), 61-67.
130. Roseman, T.J.; Brown, J.A.; Scothorn, W.W. Glass for Parenteral Products: A Surface View Using the Scanning Electron Microscope. J. Pharm. Sci. 1976, 65 (1), 22-29.
131. Bontempo, J.A. Considerations for Elastomeric Closures for Parenteral Biopharmaceutical Drugs. Drugs Pharm. Sci. 1997, 85 (Development of Biopharmaceutical Parenteral Dosage Forms), 223-240.
132. Airaudo, C.B.; Gayte-Sorbier, A.; Memburg, R.; Laurent, P. Leaching of Antioxidants and Vulcanization Accelerators from Rubber Closures into Drug Preparations. J. Biomater. Sci. Polym. Ed. 1990, 1 (4), 231-241.
133. Danielson, J.W.; Oxborrow, G.S.; Placencia, A.M. Quantitative Determination of Chemicals Leached from Rubber Stoppers into Parenteral Solutions. J. Parenter. Sci. Technol. 1984, 38 (3), 90-93.
134. Danielson, J.N.; Oxborrow, G.S.; Placencia, A.M. Chemical Leaching of Rubber Stoppers into Parenteral Solutions. J. Parenter. Sci. Technol. 1983, 37(3), 89-92.
135. Physicians' Desk Reference (Online). Medical Economics Co.: Montvale, NJ, 2000.